S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|NeoGenomics Revises Upward its Quarter 3 2013 Guidance (2013/9/26)|
|NeoGenomics Schedules its Q3 2013 Earnings Release for October 23, 2013 (2013/10/7)|
|NeoGenomics Reports Revenue of $15.6 Million, Adjusted EBITDA of $1.8 Million and Earnings per share of $0.01 for the Second Quarter 2013 ()|
|Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials (2013/11/18)|
|NeoGenomics Reports Record Revenue of $16.9 Million, Adjusted EBITDA of $2.2 Million and Net Income of $900K for the Third Quarter 2013 (2013/10/23)|
|Made in IBM Labs: New Data Discovery and Visualization Capabilities Help Business Users Uncover Hidden Patterns via the Cloud (2013/11/5)|
|Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™ (2013/9/17)|
|The Samsung ATIV S Neo Lands At AT&T, Runs On The Nation's Fastest And Most Reliable 4G LTE Network (2013/10/24)|
|Guidewire Congratulates 2013 Innovation Award Winners – AAMI, AXA France, Groupe Promutuel, Mercury Insurance, and Montana State Fund (2013/10/8)|
|Tsakos Energy Navigation Reports Six Month and Second Quarter Financial Results for the Period Ended June 30, 2013 ()|
Click above to view more mutual fund data and stats for neo - NeoGenomics, Inc..